These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Prescription for an ailing pharmaceutical industry. Demain AL Nat Biotechnol; 2002 Apr; 20(4):331. PubMed ID: 11923826 [No Abstract] [Full Text] [Related]
49. Back on target. Webb S Nat Biotechnol; 2013 Mar; 31(3):191-3. PubMed ID: 23471062 [No Abstract] [Full Text] [Related]
50. Michigan's next wave of biopharmaceutical entrepreneurship. Kerppola R; van de Walle M; Surine S Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575 [No Abstract] [Full Text] [Related]
54. India: 50 years after independence. Miller DD; Nayak AR Nat Biotechnol; 1997 Aug; 15(8):727-9. PubMed ID: 9255782 [No Abstract] [Full Text] [Related]
55. Best of both worlds. Smaglik P Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875 [No Abstract] [Full Text] [Related]
56. Market watch: Biopharma deal-making in 2014: a record year for M&A value. Micklus A; Muntner S Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786 [No Abstract] [Full Text] [Related]
57. Biotech industry faces new bottleneck. Garber K Nat Biotechnol; 2001 Mar; 19(3):184-5. PubMed ID: 11231516 [No Abstract] [Full Text] [Related]
58. Mike Varney. Varney M; Mullard A Nat Rev Drug Discov; 2015 Mar; 14(3):158-9. PubMed ID: 25677359 [No Abstract] [Full Text] [Related]
59. Where have all the investors gone?: the case for consolidation. Esposito RS; Ostro MJ Nat Biotechnol; 1998 May; 16 Suppl():63. PubMed ID: 9591277 [No Abstract] [Full Text] [Related]